(Q42486793)

1 November 2017

title

Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer (English)

1 reference

1 November 2017

1 reference

Yogesh K Vashist

1

1 reference

1 November 2017

Guentac Uzungolu

2

1 reference

1 November 2017

Asad Kutup

3

1 reference

1 November 2017

Florian Gebauer

4

1 reference

1 November 2017

Alexandra Koenig

5

1 reference

1 November 2017

Lena Deutsch

6

1 reference

1 November 2017

Oliver Zehler

7

1 reference

1 November 2017

Philipp Busch

8

1 reference

1 November 2017

Viacheslav Kalinin

9

1 reference

1 November 2017

Jakob R Izbicki

10

1 reference

1 November 2017

Emre F Yekebas

11

1 reference

1 November 2017

language of work or name

1 reference

14 April 2011

1 reference

Journal of Surgical Oncology

1 November 2017

published in

1 reference

1 November 2017

volume

104

1 reference

1 November 2017

issue

3

1 reference

1 November 2017

page(s)

305-311

1 reference

One thousand consecutive pancreaticoduodenectomies

1 November 2017

cites work

1 reference

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database.

21 January 2018

1 reference

Pancreatic cancer: a review and update

21 January 2018

1 reference

Neoadjuvant and adjuvant strategies for pancreatic cancer

21 January 2018

1 reference

Guidelines for the surgical management of pancreatic adenocarcinoma

21 January 2018

1 reference

Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress

21 January 2018

1 reference

Tumor-node-metastasis staging of pancreatic adenocarcinoma

21 January 2018

1 reference

Adjuvant therapy for pancreatic cancer: a review

21 January 2018

1 reference

Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?

21 January 2018

1 reference

Evidence-based guidelines for adjuvant therapy for resected adenocarcinoma of the pancreas.

21 January 2018

1 reference

Treatment of pancreatic adenocarcinoma: a European perspective

21 January 2018

1 reference

Progress on molecular markers of pancreatic cancer

21 January 2018

1 reference

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

21 January 2018

1 reference

Resection margins and R1 rates in pancreatic cancer--are we there yet?

21 January 2018

1 reference

Redefining the R1 resection in pancreatic cancer.

21 January 2018

1 reference

Hemoxygenase-1 in cardiovascular disease

21 January 2018

1 reference

Gene regulation of heme oxygenase-1 as a therapeutic target

21 January 2018

1 reference

Heme oxygenase and renal disease

21 January 2018

1 reference

Heme oxygenase-1 in tumors: is it a false friend?

21 January 2018

1 reference

Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection.

21 January 2018

1 reference

Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth

21 January 2018

1 reference

Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment

21 January 2018

1 reference

Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase

21 January 2018

1 reference

Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells.

21 January 2018

1 reference

HO-1 underlies resistance of AML cells to TNF-induced apoptosis

21 January 2018

1 reference

Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment

21 January 2018

1 reference

Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo

21 January 2018

1 reference

Heme oxygenase-1 inhibits the proliferation of pancreatic stellate cells by repression of the extracellular signal-regulated kinase1/2 pathway.

21 January 2018

1 reference

Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer

21 January 2018

1 reference

The role of heme oxygenase-1 promoter polymorphisms in human disease

21 January 2018

1 reference

Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema

21 January 2018

1 reference

Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers

21 January 2018

1 reference

Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism

21 January 2018

1 reference

A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma.

21 January 2018

1 reference

Microsatellite GTn-repeat polymorphism in the promoter of heme oxygenase-1 gene is an independent predictor of tumor recurrence in male oral squamous cell carcinoma patients

21 January 2018

1 reference

Haeme oxygenase-1 promoter polymorphism is an independent prognostic marker of gastrointestinal stromal tumour.

21 January 2018

1 reference

Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database

21 January 2018

1 reference

Prognostic versus predictive value of biomarkers in oncology.

21 January 2018

1 reference

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33

21 January 2018

1 reference

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer

21 January 2018

1 reference

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

Genetic variation in the HSD17B1 gene and risk of prostate cancer

21 January 2018

1 reference

Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer

21 January 2018

1 reference

Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity

21 January 2018

1 reference

Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer

21 January 2018

1 reference

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

21 January 2018

1 reference

Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort

21 January 2018

1 reference

Pharmacogenetics: a tool for individualizing antineoplastic therapy

21 January 2018

1 reference

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases

21 January 2018

1 reference

Host genetics and tumour metastasis

21 January 2018

1 reference

Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival

21 January 2018

1 reference

Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy.

21 January 2018

1 reference

d(TG)n.d(CA)n sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription

21 January 2018

1 reference

Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response

21 January 2018

1 reference

Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence--first results of an inter-ethnic breast cancer study.

21 January 2018

1 reference

Relationship between microsatellite polymorphism in the haem oxygenase-1 gene promoter and longevity of the normal Japanese population

21 January 2018

1 reference

Most Pancreatic Cancer Resections are R1 Resections

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.21926

1 reference

1 November 2017

1 reference